NYSE:RNN
Delisted

Rexahn Pharmaceuticals, Inc. Stock Predictions

$5.24
+0 (+0%)
At Close: Sep 19, 2019
Currently predicting for Tue, 28 May 2024

RNN Predictions History

7 years ago
OneTrickJohnny predicted that RNN for 2017-04-11 is going $0.690 (-89.72%)

Rank:

7 years ago
JuanC Villegas predicted that RNN for 2017-04-11 is going $0.677 (-89.91%)

7 years ago
JS predicted that RNN for 2017-04-10 is going $0.671 (-90.00%)

7 years ago
OneTrickJohnny predicted that RNN for 2017-04-10 is going $0.740 (-88.79%)

Rank:

7 years ago
JS predicted that RNN for 2017-04-07 is going $0.667 (-89.89%)

7 years ago
Sean predicted that RNN for 2017-04-07 is going $0.600 (-90.70%)

Rank:

7 years ago
OneTrickJohnny predicted that RNN for 2017-04-07 is going $0.710 (-88.99%)

Rank:

7 years ago
Jack.Cesario.Migueis.3576 predicted that RNN for 2017-04-07 is going $0.564 (-91.26%)

7 years ago
Adrian predicted that RNN for 2017-04-06 is going $0.590 (-90.44%)

Rank:

7 years ago
OneTrickJohnny predicted that RNN for 2017-04-06 is going $0.670 (-89.14%)

Rank:
Click to get the best stock tips daily for free!

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer. The company’s clinical stage oncology candidates include Archexin that completed a pilot Phase IIa clinical trial for the treatment of pancreatic cancer; RX-3117, which is in Phase Ib clinical trial for the treatment of patients with solid tumors; and Supinoxin that is in Phase I clinical trial for patients wit... RNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT